Autolus Therapeutics (AUTL) Reports In-Line Q1 EPS

Autolus Therapeutics (NASDAQ: AUTL) reported Q1 EPS of ($0.26), in-line with the analyst estimate of ($0.26).

For earnings history and earnings-related data on Autolus Therapeutics (AUTL) click here.

You May Also Be Interested In

• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
• TD Cowen: 'Chewy Inc. (CHWY) Shares Look Attractive at Current Levels'
• Piper Sandler on Fervo Energy (FRVO): 'Capital Access Supports Potential Upside'